With the rationale that a significant reduction of the malignant clone
in CML might prolong time to metamorphosis, intensive treatment was g
iven to patients less than or equal to 55 years. Six months of hydroxy
urea and high dose interferon-alpha (IFN-alpha) was followed by one to
three courses of intensive chemotherapy. Patients who had a donor wer
e allotransplanted and patients who became Ph-negative in bone marrow
were autotransplanted. On 1 May 1995, 160 patients were registered in
the study. Fifty-one percent of the patients who received six months I
FN-alpha and hydroxyurea had a significant Ph-reduction and 5% became
Ph-negative. The corresponding figures after two intensive chemotherap
y courses were 47 and 28%, respectively. Twenty-seven of 30 antotransp
lanted patients have been analysed for Ph. Seventeen have relapsed cyt
ogenetically, while ten are Ph-negative 1-64 + months after ABMT. BMT
was performed in 59 patients. The actuarial 6-year survival from diagn
osis of all 160 registered patients is 68%, which seems to be better t
han for age-matched historical controls.